[1]
“Omega-3 in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis, Effects on Inflammatory Markers and Lipid Profile”, IJKD, vol. 14, no. 2, pp. 126–132, Mar. 2020, Accessed: Dec. 03, 2024. [Online]. Available: https://ijkd.org/index.php/ijkd/article/view/4618